‌

US Patent 10689431 Compositions and methods for treating cancer with DuoCARs

Patent 10689431 was granted and assigned to Lentigen on June, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Lentigen

Current Assignee

Lentigen

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10689431

Date of Patent

June 23, 2020

Patent Application Number

16134735

Date Filed

September 18, 2018

Patent Citations Received

‌

US Patent 11878052 Compositions and methods for treating cancer with anti-CD22 immunotherapy

‌

US Patent 11802142 Compositions and methods for treating cancer with DuoCARs

Patent Primary Examiner

‌

Maria Marvich

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10689431 Compositions and methods for treating cancer with DuoCARs

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API